2 completed, 1 recruiting, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Jennifer Mitchell: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Psychedelics in Healthy Older Adults With Low Well-being Psilocybin (drug), Dextromethorphan (DXM) - Anhedonia in Healthy Volunteers, Older Adults (50-90 Years) | Phase 1 | Recruiting | Jennifer Mitchell | 80 | 2026-06-01 | 2026-09-09 |
| Oxytocin on Approach Bias and Craving Oxytocin, Placebo - Alcohol Use Disorder | Phase 2 | Withdrawn | Jennifer Mitchell | 2023-11-01 | 2022-06-06 | |
| Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress Oxytocin, Placebo - Alcohol Use Disorder, Stress Disorders, Post-Traumatic | Phase 2 | Completed | Jennifer Mitchell | 63 | 2017-04-20 | 2020-10-19 |
| Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users Tolcapone, Placebo - Alcohol Abuse, Impulsive Behavior | Phase 2 | Completed | Jennifer Mitchell | 62 | 2016-10-01 | 2020-09-21 |
Alcoholism (3) · Anxiety Disorders (1) · Impulsive Behavior (1) · Neuroinflammatory Diseases (1) · Stress Disorders, Post-Traumatic (1) · Substance-Related Disorders (1)
Oxytocin (2) · Dextromethorphan (1) · Pharmaceutical Preparations (1) · Psilocybin (1) · Tolcapone (1)
United States (4)
Lorenzo Pasquini, PhD (1) · Mardi Smith, PhD (1)